230 related articles for article (PubMed ID: 30670825)
1. Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia.
Xu ZL; Zhou M; Jia JS; Mo WJ; Zhang XH; Zhang YP; Wang Y; Li YM; Huang XJ; Wang SQ; Xu LP
Bone Marrow Transplant; 2019 Aug; 54(8):1319-1326. PubMed ID: 30670825
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
Front Immunol; 2022; 13():837335. PubMed ID: 35178053
[TBL] [Abstract][Full Text] [Related]
3. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
Geng C; Liu X; Chen M; Yang C; Han B
Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia.
Liu L; Zhang Y; Jiao W; Zhou H; Wang Q; Jin S; Cai Y; Zhao L; Shangguan X; Liu Z; Xu J; Lei M; Yan X; Miao M; Wu D
Leukemia; 2020 Dec; 34(12):3359-3369. PubMed ID: 32591644
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
[TBL] [Abstract][Full Text] [Related]
6. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
[TBL] [Abstract][Full Text] [Related]
7. First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy.
Cheng Y; Xu Z; Zhang Y; Wu J; Wang F; Mo X; Chen Y; Han W; Jia J; Wang Y; Zhang X; Huang X; Zhang L; Xu L
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29297952
[TBL] [Abstract][Full Text] [Related]
8. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study.
Li Y; Duan F; Xiao H; Wu X; Wang S; Xu D; Liu Q; Fan Z; Nie D; Lai Y; Wu B; Lin D; Du X; Weng J; Jiang Z; Pang Y; Ouyang L; Liu Z; Zhang L; Han N; Chen L; Xiao Y
Transplantation; 2018 Oct; 102(10):1724-1731. PubMed ID: 29677078
[TBL] [Abstract][Full Text] [Related]
10. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
Xu LP; Jin S; Wang SQ; Xia LH; Bai H; Gao SJ; Liu QF; Wang JM; Wang X; Jiang M; Zhang X; Wu DP; Huang XJ
J Hematol Oncol; 2017 Jan; 10(1):25. PubMed ID: 28107815
[TBL] [Abstract][Full Text] [Related]
11. Current insights into the treatments of severe aplastic anemia in China.
Ye L; Zhang F; Kojima S
Int J Hematol; 2020 Sep; 112(3):292-299. PubMed ID: 32748215
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis-associated aplastic anemia.
Zhang X; Yang W; Yang D; Wei J; Zhang P; Feng S; Jiang E; Zhang L; He Y; Zhang F; Han M
Front Immunol; 2023; 14():1146997. PubMed ID: 37006284
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
[TBL] [Abstract][Full Text] [Related]
14. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
[TBL] [Abstract][Full Text] [Related]
15. Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.
Wu LQ; Huang LF; Yang H; Ye BD; Sheng JP; Yu QH; Yang Y; Jia JS; Zhang DH; Lin SY; He GS; Li JY
Ann Hematol; 2023 Aug; 102(8):2015-2023. PubMed ID: 37193759
[TBL] [Abstract][Full Text] [Related]
16. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia.
Marsh JCW; Risitano AM; Mufti GJ
Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354
[TBL] [Abstract][Full Text] [Related]
17. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
[TBL] [Abstract][Full Text] [Related]
18. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
Liu L; Lei M; Fu R; Han B; Zhao X; Liu R; Zhang Y; Jiao W; Miao M; Zhang F; Zhang L; Wu D
J Hematol Oncol; 2022 Aug; 15(1):105. PubMed ID: 35962406
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor.
Choi YB; Yi ES; Lee JW; Sung KW; Koo HH; Yoo KH
Bone Marrow Transplant; 2017 Jan; 52(1):47-52. PubMed ID: 27668766
[TBL] [Abstract][Full Text] [Related]
20. [Outcome of combination of HLA-haploidentical hematopoietic SCT with an unrelated cord blood unit for 127 patients with acquired severe aplastic anemia].
Liu LM; Zhang YM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Sun AN; Miao M; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):624-628. PubMed ID: 30180460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
